|
AU2011205048A1
|
|
Compounds and methods for the treatment or prevention of flavivirus infections
|
|
EP2257567A1
|
|
Novel 17 beta lupane derivatives
|
|
EP2240504A1
|
|
Novel c-21-keto lupane derivatives preparation and use thereof
|
|
AU2008342537A1
|
|
Novel lupane derivatives
|
|
CN102675279A
|
|
Thiophene analogues for the treatment or prevention of flavivirus infections
|
|
CA2655203A1
|
|
Spirotropane compounds
|
|
WO2007065256A1
|
|
Novel spiropiperidine compounds and methods for the modulation of chemokine receptor activity
|
|
WO2006119646A1
|
|
Compounds and methods for the treatment or prevention of flavivirus infections
|
|
CA2634499A1
|
|
Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase
|
|
CN101098871A
|
|
Novel spirotropane compounds and methods for the modulation of chemokine receptor activity
|
|
MX2007006776A
|
|
Novel spirotropane compounds and methods for the modulation of chemokine receptor activity.
|
|
CA2590737A1
|
|
Novel spirotropane compounds and methods for the modulation of chemokine receptor activity
|
|
US2006014769A1
|
|
Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
|
|
WO2005042524A1
|
|
Pyridine carboxamide and methods for inhibiting hiv integrase
|
|
WO2005023810A1
|
|
Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
|
|
CA2579608A1
|
|
Spiro compounds and methods for the modulation of chemokine receptor activity
|
|
CA2573951A1
|
|
Spiro compounds and methods for the modulation of chemokine receptor activity
|
|
WO2004052879A1
|
|
Thiophenederivatives for the treatment of flavivirus infections
|
|
US7402608B2
|
|
Compounds and methods for the treatment or prevention of Flavivirus infections
|
|
NZ540799A
|
|
Compounds and methods for the treatment or prevention of flavivirus infections
|
